Despite a lack of large randomized trials clarifying when and in whom it might work best, use of Impella (Abiomed) for mechanical circulatory support in patients with acute MI complicated by ...

Several studies show that the use of percutaneous ventricular assist devices (PVADs), including Impella, is particularly cost-effective in cases of cardiogenic shock: Several studies, including ...

DANVERS, Mass.--(BUSINESS WIRE)--The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Impella RP to include patients suffering from COVID-19 related ...

The study demonstrated Impella ECP's safety and efficacy for use in high-risk PCI. Operators chose 8Fr Angio-Seal as the first-closure method in 70% of the patients, with a 92% success rate 1.

Chonnam National University Hospital succeeded in introducing Impella for the first time in the coun... Chonnam National ...

The FDA has opened up the use of Johnson & Johnson’s miniaturized heart pumps to certain pediatric patients, including those suffering from acute heart failure and cardiogenic shock. The agency ...

Study conducted at 109 hospitals with oversight by 10 Japanese professional societies, including Japanese Circulation Society Figure 1 (Graphic: Business Wire) The interim analysis examined 819 ...

DANVERS, Mass.--(BUSINESS WIRE)--The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide left ventricular ...

CLEVELAND — Forty-one-year-old Mark Kader is a husband, father of five, registered nurse, and associate clinical consultant for Abiomed, a medical device company. He's passionate about educating ...

isa Cardillo, then 36, and her husband were celebrating their 15th wedding anniversary and had just checked into a bed-and-breakfast when she felt a burning, stabbing pain in her chest. She was having ...

Use of the Impella percutaneous left ventricular assist device (Abiomed) in acute MI complicated by cardiogenic shock (AMICS) in the United States increased nearly fivefold between 2012 and 2017, a ...

DANVERS, Mass. – October 28, 2024 – Results were presented at Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference from the first completed pivotal trial on patients supported with Impella ...